Interventions for Tuberculosis Control and Elimination 2002

989. Hoffner SE, Källenius G. Susceptibility of streptomycin-resistant Mycobacterium
tuberculosis strains to amikacin. Eur J Clin Microbiol 1988; 7: 188-90.
990. Donald PR, Sirgel FA, Venter A, Smit E, Parkin DP, Van de Wal BW,
Mitchison DA. The early bactericidal activity of amikacin in pulmonary tuberculosis.
Int J Tuberc Lung Dis 2001; 5: 533-8.
991. Singh YN, Marshall IG, Harvey AL. Some effects of the aminoglycoside amikacin
on neuromuscular and autonomic transmission. Br J Anaesth 1978; 50: 109-17.
992. Dehpour AR, Samadian T, Roushanzamir F. Interaction of aminoglycoside
antibiotics and lithium at the neuromuscular junction.
1992; 18: 383-7.
Drugs Exptl Clin Res
993. Zarfin Y, Koren G, Maresky D, Perlman M, MacLeod S. Possible indomethacinaminoglycoside
interaction in preterm infants. J Pediatr 1985; 106: 511-2.
994. Umezawa H, Ueda M, Maeda K, Yagishita K, Kondo S, Okami Y, Utahara R,
Osato Y, Nitta K, Takeguchi T. Production and isolation of a new antibiotic,
kanamycin. J Antibiotics Japan Ser A 1957; 10: 181-8.
995. Umezawa S, Tatsuta K, Koto S.
Antibiotics 1968; 21: 367-8.
The total synthesis of kanamycin A. J
996. Umezawa S, Koto S, Tatsuta K, Hineno H, Nishimura Y, Tsumura T. The total
synthesis of kanamycin B. J Antibiotics 1968; 21: 424-5.
997. Umezawa S, Koto S, Tatsuta K, Tsumura T. The total synthesis of kanamycin
C. J Antibiotics 1968; 21: 162-3.
998. Bunn PA. Kanamycin. Med Clin N Am 1970; 54: 1245-57.
999. Rempt E. Gehörschäden bei Kanamycinlangzeittherapie. Zeitschr Laryngol
Rhinol Otol 1970; 49: 504-9.
1000. Alberghina M, Nicoletti G, Torrisi A. Genetic determinants of aminoglycoside
resistance in strains of Mycobacterium tuberculosis.
148-60.
Chemotherapy 1973; 19:
1001. Herr JB, Jr, Haney ME, Pittenger GE, Higgins CE. Isolation and characterization
of a new peptide antibiotic. Proc Ind Acad Sci 1959; 69: 134.
1002. Ho YII, Chan CY, Cheng AFB. In-vitro activities of aminoglyoside-aminocyclitols
against mycobacteria. J Antimicrob Chemother 1997; 40: 27-32.
1003. Heifets L, Lindholm-Levy P. Comparison of bactericidal activities of streptomycin,
amikacin, kanamycin, and capreomycin against Mycobacterium avium
and M. tuberculosis Antimicrob Agents Chemother 1989; 33: 1298-301.
1004. Aquinas M, Citron KM. Rifampicin, ethambutol and capreomycin in pulmonary
tuberculosis, previously treated with both first and second line drugs: the results
of 2 years chemotherapy. Tubercle 1972; 53: 153-65.
1005. McClatchy JK, Kanes W, Davidson PT, Moulding TS. Cross-resistance in
M. tuberculosis to kanamycin, capreomycin and viomycin.
29-34.
Tubercle 1977; 58:
236